iShares NASDAQ Biotechnology Index (IBB) Shares Sold by Financial Partners Group Inc

Financial Partners Group Inc lessened its holdings in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 1.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 33,284 shares of the financial services provider’s stock after selling 607 shares during the period. iShares NASDAQ Biotechnology Index comprises approximately 2.6% of Financial Partners Group Inc’s holdings, making the stock its 13th largest holding. Financial Partners Group Inc’s holdings in iShares NASDAQ Biotechnology Index were worth $4,059,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Schroder Investment Management Group bought a new stake in iShares NASDAQ Biotechnology Index during the 2nd quarter valued at approximately $105,000. Benjamin F. Edwards & Company Inc. boosted its position in iShares NASDAQ Biotechnology Index by 636.4% during the 3rd quarter. Benjamin F. Edwards & Company Inc. now owns 891 shares of the financial services provider’s stock valued at $109,000 after acquiring an additional 770 shares in the last quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors bought a new stake in iShares NASDAQ Biotechnology Index during the 2nd quarter valued at approximately $134,000. KHP Capital LLC boosted its position in shares of iShares NASDAQ Biotechnology Index by 61.1% in the 2nd quarter. KHP Capital LLC now owns 1,450 shares of the financial services provider’s stock worth $159,000 after purchasing an additional 550 shares in the last quarter. Finally, Private Wealth Advisors Inc. bought a new stake in shares of iShares NASDAQ Biotechnology Index in the 2nd quarter worth approximately $201,000. 63.62% of the stock is currently owned by institutional investors and hedge funds.

Shares of IBB opened at $108.10 on Monday. iShares NASDAQ Biotechnology Index has a 52 week low of $100.22 and a 52 week high of $122.97.

iShares NASDAQ Biotechnology Index Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Article: What do investors mean by earnings per share?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares NASDAQ Biotechnology Index (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply